XML 87 R61.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Financial Assets at Fair Value Through Other Comprehensive Income (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Financial Assets at Fair Value Through Other Comprehensive Income [Abstract] |
Schedule of Financial Asset | As of December 31, 2023 and 2022, financial assets are detailed as follows:
|  | 2023 |  |  | 2022 |
|  | MCh$ |  |  | MCh$ |
Debt Financial Instruments |  |  | 3,786,525 |  |  |  | 3,967,392 |
Equity Instruments |  |  | 11,912 |  |  |  | 6,545 |
Total |  |  | 3,798,437 |  |  |  | 3,973,937 |
| (a) | Debt Financial Instruments at fair value through OCI:
Schedule of Debt Financial Instruments | As of December 31, 2023 and 2022 the detail of debt financial instruments is as follows:
|  | 2023 |  |  | 2022 |
|  | MCh$ |  |  | MCh$ |
Instruments issued by the Chilean Government and Central Bank of Chile |  |  |  |  |  |
Debt financial instruments from the Central Bank of Chile |  |  | 473,642 |  |  |  | — |
Bonds and Promissory notes from the Chilean Government |  |  | 1,362,510 |  |  |  | 2,254,578 |
Other fiscal debt financial instruments |  |  | 1,500 |  |  |  | 4,279 |
Other Instruments Issued in Chile |  |  |  |  |  |  |  |
Debt financial instruments from other domestic banks |  |  | 1,681,744 |  |  |  | 1,494,914 |
Bonds and trade effects from domestic companies |  |  | 59,921 |  |  |  | 45,994 |
Other debt financial instruments issued in the country |  |  | — |  |  |  | — |
Instruments Issued Abroad |  |  |  |  |  |  |  |
Financial instruments from foreign Central Banks |  |  | — |  |  |  | — |
Financial instruments from foreign governments and fiscal entities |  |  | 43,294 |  |  |  | 42,017 |
Debt financial instruments from other foreign banks |  |  | 163,914 |  |  |  | 125,610 |
Bonds and trade effects from foreign companies |  |  | — |  |  |  | — |
Other debt financial instruments issued abroad |  |  | — |  |  |  | — |
Total |  |  | 3,786,525 |  |  |  | 3,967,392 |
| * | Net change between assets purchased and assets derecognized excluding write offs.
| ** | Represents the change in the year-end ECLs of exposures that were transferred from one stage to another during the year.
Schedule of Credit Ratings of the Issuers of Debt Instruments | The credit ratings of the issuers of debt instruments as of December 31, 2023 and 2022, are as follows:
|  | As of December 31, 2023 |  |  | As of December 31, 2022 |
|  | Stage 1 Individual |  |  | Stage 2 Individual |  |  | Stage 3 Individual |  |  | Total Individual |  |  | Stage 1 Individual |  |  | Stage 2 Individual |  |  | Stage 3 Individual |  |  | Total Individual |
|  | MCh$ |  |  | MCh$ |  |  | MCh$ |  |  | MCh$ |  |  | MCh$ |  |  | MCh$ |  |  | MCh$ |  |  | MCh$ |
Debt Instrument |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investment grade |  |  | 3,786,525 |  |  |  | — |  |  |  | — |  |  |  | 3,786,525 |  |  |  | 3,967,392 |  |  |  | — |  |  |  | — |  |  |  | 3,967,392 |
Non-investment grade |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Without rating |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Total |  |  | 3,786,525 |  |  |  | — |  |  |  | — |  |  |  | 3,786,525 |  |  |  | 3,967,392 |  |  |  | — |  |  |  | — |  |  |  | 3,967,392 |
| (a.2) | Analysis of changes in the fair value and corresponding allowance for ECL by stage for debt instruments measured at FVOCI as of December 31, 2023 and 2022, is as follows:
Schedule of Changes in Fair Value and Corresponding Allowance for ECL | Analysis of changes in the fair value and corresponding allowance for ECL by stage for debt instruments measured at FVOCI as of December 31, 2023 and 2022, is as follows:
|  | Stage 1 Individual |  |  | Stage 2 Individual |  |  | Stage 3 Individual |  |  | Total |
|  | Fair value MCh$ |  |  | ECL MCh$ |  |  | Fair value MCh$ |  |  | ECL MCh$ |  |  | Fair value MCh$ |  |  | ECL MCh$ |  |  | Fair value MCh$ |  |  | ECL MCh$ |
Balance as of January 1, 2022 |  |  | 3,054,795 |  |  |  | 4,085 |  |  |  | 14 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 3,054,809 |  |  |  | 4,085 |
Net change on Balance * |  |  | 864,521 |  |  |  | 5,411 |  |  |  | (14 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 864,507 |  |  |  | 5,411 |
Change in fair value |  |  | 48,076 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 48,076 |  |  |  | — |
Transfer to Stage 1 |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Transfer to Stage 2 |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Transfer to Stage 3 |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Impact on year-end ECL of exposures transferred between stages during the year ** |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Impact of net re-measurement of year-end ECL |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Amounts written off |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Foreign exchange adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Balance as of December 31, 2022 |  |  | 3,967,392 |  |  |  | 9,496 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 3,967,392 |  |  |  | 9,496 |
Balance as of January 1, 2023 |  |  | 3,967,392 |  |  |  | 9,496 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 3,967,392 |  |  |  | 9,496 |
Net change on Balance * |  |  | (159,617 | ) |  |  | (3,996 | ) |  |  | (30,124 | ) |  |  | (1,921 | ) |  |  | — |  |  |  | — |  |  |  | (189,741 | ) |  |  | (5,917 | )
Change in fair value |  |  | 8,718 |  |  |  | — |  |  |  | 156 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 8,874 |  |  |  | — |
Transfer to Stage 1 |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Transfer to Stage 2 |  |  | (29,968 | ) |  |  | — |  |  |  | 29,968 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Transfer to Stage 3 |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Impact on year-end ECL of exposures transferred between stages during the year ** |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,921 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,921 |
Impact of net re-measurement of year-end ECL |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Amounts written off |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Foreign exchange adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Balance as of December 31, 2023 |  |  | 3,786,525 |  |  |  | 5,500 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 3,786,525 |  |  |  | 5,500 |
| * | Net change between assets purchased and assets derecognized excluding write offs.
| ** | Represents the change in the year-end ECLs of exposures that were transferred from one stage to another during the year.
Schedule of Detail of Equity Instruments | As of December 31, 2023 and 2022, the detail of equity instruments is as follows:
|  | 2023 |  |  | 2022 |
|  | MCh$ |  |  | MCh$ |
Equity instruments issued in Chile |  |  | 10,601 |  |  |  | 5,700 |
Equity instruments issued by foreign institutions |  |  | 1,311 |  |  |  | 845 |
Total |  |  | 11,912 |  |  |  | 6,545 |
Schedule of Gross Realized Gains and Losses on the Sale of Debt Financial Instruments | Gross realized gains and losses on the sale of debt financial instruments, as of December 31, 2023, 2022 and 2021 are reported under “Net Financial income (expense)” (See Note No. 31). The realized gains and losses at the end of both periods are the following:
|  | 2023 |  |  | 2022 |  |  | 2021 |
|  | MCh$ |  |  | MCh$ |  |  | MCh$ |
Unrealized gains (losses) |  |  | 4,352 |  |  |  | (15,325 | ) |  |  | (50,475 | )
Realized losses (gains) reclassified to income |  |  | 4,522 |  |  |  | 63,401 |  |  |  | (1,242 | )
Subtotal |  |  | 8,874 |  |  |  | 48,076 |  |  |  | (51,717 | )
Income tax on other comprehensive income |  |  | (1,806 | ) |  |  | 798 |  |  |  | 4,171 |
Net effect in equity |  |  | 7,068 |  |  |  | 48,874 |  |  |  | (47,546 | )

X
- Definition The disclosure of fair value of investments in debt instruments designated at fair value through other comprehensive income. + References No definition available. + Details
Name: | bch_DisclosureOfFairValueOfInvestmentsInDebtInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTextBlock
Namespace Prefix: | bch_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of gain and loss on available for sale investments. + References No definition available. + Details
Name: | bch_DisclosureOfUnrealisedGainAndLossOnAvailableForSaleInvestmentsTableTextBlock
Namespace Prefix: | bch_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | bch_ScheduleOfChangesInCorrespondingEclsOfDebtInstrumentTableTextBlock
Namespace Prefix: | bch_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The tabular disclosure of credit ratings of the issuers of debt securities. + References No definition available. + Details
Name: | bch_ScheduleOfCreditRatingTableTextBlock
Namespace Prefix: | bch_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of Detail of Equity Instruments. + References No definition available. + Details
Name: | bch_ScheduleOfDetailOfEquityInstrumentsTableTextBlock
Namespace Prefix: | bch_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2023-01-01 -Section Scope -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration